Patents by Inventor Slobodon Vukicevic

Slobodon Vukicevic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100291170
    Abstract: The present invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of chronic renal failure, or at risk of a need for renal replacement therapy. The methods involve the administration of certain proteins of, or based upon, the osteogenic protein/bone morphogenetic protein (OP/BMP) family within the TGF-? superfamily of proteins.
    Type: Application
    Filed: March 16, 2009
    Publication date: November 18, 2010
    Applicant: STRYKER CORPORATION
    Inventors: KUBER T. SAMPATH, CHARLES M. COHEN, SLOBODON VUKICEVIC
  • Patent number: 7524817
    Abstract: The present invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of chronic renal failure, or at risk of a need for renal replacement therapy. The methods involve the administration of certain proteins of, or based upon, the osteogenic protein/bone morphogenetic protein (OP/BMP) family within the TGF-? superfamily of proteins.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: April 28, 2009
    Assignee: Stryker Corporation
    Inventors: Charles M. Cohen, Kuber T. Sampath, Slobodon Vukicevic
  • Publication number: 20050143304
    Abstract: The present invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of chronic renal failure, or at risk of a need for renal replacement therapy. The methods involve the administration of certain proteins of, or based upon, the osteogenic protein/bone morphogenetic protein (OP/BMP) family within the TGF-? superfamily of proteins.
    Type: Application
    Filed: December 17, 2004
    Publication date: June 30, 2005
    Applicant: Curis, Inc.
    Inventors: Charles Cohen, Kuber Sampath, Slobodon Vukicevic
  • Patent number: 6861404
    Abstract: The present invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of chronic renal failure, or at risk of a need for renal replacement therapy. The methods involve the administration of certain proteins of, or based upon, the osteogenic protein/bone morphogenetic protein (OP/BMP) family within the TGF-?superfamily of proteins.
    Type: Grant
    Filed: May 6, 1997
    Date of Patent: March 1, 2005
    Assignee: Curis, Inc.
    Inventors: Charles M. Cohen, Kuber T. Sampath, Slobodon Vukicevic